<DOC>
	<DOCNO>NCT01870115</DOCNO>
	<brief_summary>The investigator ' long-term goal employ novel method improve bone formation bone density woman ( men ) osteopenia osteoporosis also decrease sign symptom degenerative joint disc disease commonly accompany bone loss well improve quality life ( QOL ) . These condition generally begin silently early menopause transition progress osteopenia osteoporosis post-menopausal year age woman . The investigator also envision beneficial age andropausal men condition . The investigator postulate melatonin novel combination natural bone-protective agent may act `` chronosynergy '' manner prevent correct perturbation , reduce risk bone fracture , lessen stiffness pain associate bone , joint cartilage degeneration improve quality life ( QOL ) . The objective , investigator ' next step pursuit goal , assess efficacy alternative therapy use novel combination bone-forming agent , melatonin , strontium ( citrate ) / vitamin K2 ( MK7 ) , vitamin D3 bone health postmenopausal population . Melatonin novel alternative current treatment ( ) multiple bone-protective sleep-promoting activity within body , relatively safe use age population without untoward side effect ; strontium vitamin D3 show enhance bone mineralization improve post-menopausal osteoporosis . The project goal identify combination therapy improve bone health QOL compare woman take placebo . The investigator ' central hypothesis combination therapy use melatonin , strontium , vitamin K2 , vitamin D3 improve bone health overall QOL postmenopausal woman take regimen reduce osteoclast activity increase osteoblast activity improve subjective measure stress , anxiety , depression menopause-related symptom .</brief_summary>
	<brief_title>Melatonin-Micronutrients Osteopenia Treatment Study</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Vitamin K</mesh_term>
	<mesh_term>Vitamin K 2</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Vitamin MK 7</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>postmenopausal must osteopenic ( Tscore 2.5 1 ) willingness participate 12month study willingness undergo test bone turnover marker drug therapy willingness provide selfassessment quality life throughout program willingness take treatment right bed willingness consume alcohol medication woman osteopenia result know process ( e.g . hyperparathyroidism , metastatic bone disease , multiple myeloma chronic steroid use ) . woman osteoporotic drug , hypnotic , CYP1A2 inhibit drug , fluvoxamine woman severe sleep apnea , severe COPD moderate severe hepatic renal impairment .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Melatonin</keyword>
	<keyword>Strontium Citrate</keyword>
	<keyword>Osteoporosis</keyword>
	<keyword>Osteopenia</keyword>
</DOC>